Educational & Research Use Only. Not medical advice. Compounds are research-grade and not FDA-approved unless explicitly noted.
05
Section 05 · 8 compounds compounds

Neurological Repair & Neurocognitive Support

Peptides studied for cognition, neuroprotection, and emotional regulation.

Home/ Sections/ Neurological Repair & Neurocognitive Support

The brain doesn't just think — it heals, adapts, and rewires. The peptides in this section are studied for cognition, neuroplasticity, neuroprotection, and emotional resilience. From hippocampal regeneration to anxiety modulation, they target the molecular conductors of mind.

Click any peptide below to expand. Each entry covers what it is, what it's being studied to do, why it matters, potential impact, and common research pairings, with quick facts in the sidebar.

Mixture of Neuropeptides & Amino Acids · Decades of Clinical Use

Cerebrolysin is a purified mixture of low-molecular-weight neuropeptides and amino acids derived from porcine brain tissue. It contains fragments that mimic natural neurotrophic factors — BDNF, NGF, and GDNF — produced in the human brain. It has been used clinically in many countries for decades (stroke, traumatic brain injury, dementia) and is one of the most established neurotrophic compounds in research, though it isn't FDA-approved in the United States.

What It's Being Studied To Do

  • Support neuronal survival and protect against damage in ischemia or inflammation models
  • Promote neuroplasticity by enhancing synaptic formation and dendritic growth
  • Improve cognitive functions — memory, attention, executive processing
  • Accelerate recovery after neurological injury (stroke, TBI, neurodegeneration)
  • Increase neurotrophic factor expression (BDNF, NGF)
  • Provide anti-inflammatory and antioxidant effects in brain tissue

Why This Matters

Neurons have limited regenerative ability once damaged, and modern stressors accelerate decline — leading to memory lapses, reduced focus, mood instability, or slower recovery from injury. Cerebrolysin research aims to bolster the brain's built-in repair and adaptation systems, helping restore clearer thinking, emotional balance, and resilience.

Potential Impact Being Explored

Extensive clinical studies (especially in Europe and Asia) and meta-analyses suggest improvements in cognitive scores post-stroke or TBI, better functional recovery in neurodegenerative models, enhanced memory and attention in aging or mild cognitive impairment, reduced neuroinflammation markers, and overall support for brain vitality.

Common Research Pairings

Semax · BDNF and cognitive enhancementSelank · anxiety/stress balanceDihexa · stronger synaptogenesisNAD+ · neural energy support

Small Molecule · Crosses Blood-Brain Barrier · One of the Most Potent Synaptogenic Agents Studied

Dihexa is technically a small molecule, not a peptide — derived from angiotensin IV research. It earns its place in this section because it potently mimics and amplifies hepatocyte growth factor (HGF) signaling through the c-Met receptor. It crosses the blood-brain barrier efficiently and has a remarkably long half-life in research models, making it one of the most powerful synaptogenic agents studied to date.

Synaptogenesis, PlainlyMemory and learning depend on having lots of strong, dense connections between brain cells. Dihexa is studied for its ability to build new connections — like adding more wires to a network so signals travel faster and don't get lost.

What It's Being Studied To Do

  • Dramatically promote synaptogenesis (new synapse formation between neurons)
  • Enhance long-term potentiation (the cellular basis of learning and memory)
  • Improve memory consolidation and recall in aging or injury models
  • Support dendritic arborization (branching of neuron connections)
  • Provide neuroprotection against degeneration
  • Potentially reverse cognitive deficits in neurodegenerative or traumatic models

Why This Matters

Cognitive function depends on dense, adaptable synaptic networks — damage or aging thins these connections, leading to forgetfulness, slower thinking, or difficulty learning. Dihexa research explores supercharging the brain's natural growth-factor pathways to rebuild and strengthen these networks, potentially restoring mental sharpness and learning capacity.

Potential Impact Being Explored

Preclinical animal studies (including landmark 2010s work and ongoing follow-ups) show profound increases in synaptic density, reversal of memory deficits in Alzheimer's-like models, enhanced cognitive performance in aging rodents, and accelerated recovery after brain injury — frequently described as one of the most potent synaptogenic agents studied.

Common Research Pairings

Semax · BDNF supportCerebrolysin · neurotrophic synergySelank · mood/stress modulationNAD+ · energy for remodeling

7 Amino Acids · ACTH 4-10 Fragment · Russian Clinical Use

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10). Developed in Russia, where it's been used clinically for cognitive enhancement, stroke recovery, and neuroprotection, it has a strong international research footprint as a nootropic and neuroprotective compound.

What It's Being Studied To Do

  • Upregulate BDNF and other neurotrophic factors
  • Enhance dopamine and serotonin signaling for improved focus and mood
  • Promote neuroplasticity and synaptic strength
  • Support attention, memory consolidation, and learning speed
  • Provide neuroprotection against stress, ischemia, or toxins
  • Accelerate recovery after stroke, concussion, or chronic stress

Why This Matters

BDNF is like fertilizer for brain cells — higher levels support learning, mood stability, and resilience to stress, while low levels are linked to depression, anxiety, cognitive decline, and poor recovery. Semax research explores how targeted neurotrophic and neurotransmitter support might help restore mental clarity, emotional balance, and adaptive thinking — bringing the brain closer to a sharp, calm, resilient state.

Potential Impact Being Explored

Russian clinical data and international preclinical studies frequently report improved focus and mental stamina, better memory retention, reduced anxiety under stress, faster recovery from brain injury or fatigue, and enhanced cognitive performance — especially in high-demand or recovery scenarios.

Common Research Pairings

Selank · cognitive + anxiolytic balanceCerebrolysin · neurotrophic repairPE-22-28 / Dihexa · BDNF synergyNAD+ · neuronal energy

7 Amino Acids · Tuftsin Analog · Calm Without Sedation

Selank is a synthetic heptapeptide developed as an analog of tuftsin, a natural immunomodulatory peptide. Russian researchers have studied and used it clinically for anxiety, cognitive enhancement, and immune regulation. Structurally related to melanocortin peptides but designed without pigmentation effects, Selank's signature characteristic is producing calm without sedation.

What It's Being Studied To Do

  • Reduce anxiety and stress responses without sedation (modulation of GABA, serotonin, enkephalin systems)
  • Improve mood stability and emotional regulation
  • Enhance cognitive performance — focus, attention, learning under stress
  • Support immune balance by modulating inflammatory cytokines
  • Protect against neurological stress or fatigue
  • Promote a calm, clear mental state in challenging conditions

Why This Matters

Chronic stress and anxiety disrupt brain signaling, impair sleep, weaken immunity, and cloud thinking — creating a cycle that affects every part of life. Selank's research explores how gentle neurotransmitter and immune modulation might help restore emotional balance and mental clarity, allowing the brain to function as designed: resilient, focused, at peace.

Potential Impact Being Explored

Reduced anxiety scores, improved mood and stress resilience, better cognitive performance during high-pressure tasks, decreased inflammatory markers in brain tissue, and an enhanced sense of calm and focus — without the drowsiness or dependency of many traditional anxiolytics.

Common Research Pairings

Semax · cognitive + anxiety synergyCerebrolysin · neurotrophic recoveryPE-22-28 · BDNF/mood supportNAD+ · stress protection

Spadin-Derived · TREK-1 Channel Inhibitor · Fast-Acting Mood Effects

PE-22-28 is a synthetic 7-amino-acid peptide fragment derived from spadin, a naturally occurring peptide that inhibits TREK-1 potassium channels in the brain. By blocking TREK-1, PE-22-28 indirectly boosts BDNF signaling. It's a newer compound with promising preclinical data and is notable for its rapid effects compared to traditional mood modulators.

What It's Being Studied To Do

  • Rapidly increase BDNF expression
  • Enhance neuroplasticity and synaptic strength
  • Support mood regulation in depressive-like models
  • Improve stress resilience and emotional adaptability
  • Promote antidepressant-like effects without typical SSRI delays
  • Protect against chronic stress-induced neuronal changes

Why This Matters

Low BDNF levels are strongly linked to mood disorders, chronic stress, reduced cognitive flexibility, and poor resilience — issues that affect millions. PE-22-28 research explores how quickly amplifying this key "brain fertilizer" might help restore emotional balance, mental adaptability, and long-term brain health.

Potential Impact Being Explored

Preclinical studies (including 2020s work on TREK-1 inhibition) show rapid mood-lifting effects, increased BDNF in key brain regions (hippocampus, prefrontal cortex), improved stress coping, enhanced cognitive flexibility, and potential reversal of depressive-like behaviors — often described as a fast-acting neurotrophic approach with good tolerability.

Common Research Pairings

Semax · BDNF + cognitive synergySelank · mood/anxiety balanceDihexa or Cerebrolysin · stronger synaptogenesisNAD+ · cellular energy

Glu-Asp-Arg Tripeptide · Khavinson Bioregulator Family

Pinealon is a synthetic tripeptide (glutamyl-aspartyl-arginine) belonging to the class of short peptide bioregulators originally developed in Eastern European longevity research, especially the work of Prof. Vladimir Khavinson. It's designed to target pineal gland and brain tissue gene expression, and is studied for epigenetic and neuroprotective effects.

What It's Being Studied To Do

  • Support neuronal survival and function
  • Modulate gene expression related to aging and neuroprotection (antioxidant enzymes, DNA repair)
  • Improve cognitive performance — memory, attention, processing speed in aging models
  • Regulate circadian rhythm and pineal melatonin production
  • Reduce oxidative stress and inflammation in brain tissue
  • Promote healthier brain aging by influencing epigenetic markers

Why This Matters

Pineal gland and brain age-related changes contribute to cognitive slowdown, disrupted sleep, and reduced resilience over time. Pinealon's research explores how short peptides might influence gene-level regulation to help maintain neuronal health and clarity — supporting the brain's design for lifelong function and restful cycles rather than inevitable decline.

Potential Impact Being Explored

Studies (primarily from Russian longevity research institutes) suggest improved memory and cognitive scores in aged models, better circadian regulation, reduced markers of oxidative brain damage, enhanced neuroprotection in stress contexts, and potential support for healthy brain longevity.

Common Research Pairings

Epitalon · telomere + pineal synergyNAD+ · DNA repair + energySemax / Cerebrolysin · neurotrophic boostDSIP · sleep/circadian reinforcement

Synthetic Neuropeptide · Russian-developed cognitive support

ADAMAX is a synthetic pentapeptide developed in Russia, structurally related to the Semax family of regulatory peptides. It is studied for its ability to amplify natural neurotrophic signaling — particularly brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) — while modulating dopaminergic and serotonergic tone. The result is a peptide tool that researchers use to probe how the brain maintains attention, memory, and emotional resilience under cognitive load.

Plain-Language PictureThink of ADAMAX as a tuner for the brain's signal-to-noise ratio — sharpening the signals that matter (focus, memory, motivation) while quieting the static of stress and distraction.

What It's Being Studied To Do

  • Increase expression of BDNF and NGF, the neurotrophic proteins the brain uses to maintain and grow connections
  • Modulate dopamine, serotonin, and norepinephrine systems for attention and mood balance
  • Enhance memory consolidation and learning capacity in research models
  • Reduce stress-related neuronal damage by supporting the body's own neuroprotective signaling
  • Support neurogenesis in the hippocampus — the seat of memory formation

Why This Matters

Modern cognitive load and chronic stress shrink the very brain regions we rely on for clarity and emotional steadiness. ADAMAX research explores how to support the molecular tools the brain already uses to maintain itself — restoring focus and resilience where everyday demands have worn them down.

Potential Impact Being Explored

Improvements in working memory, attention span, stress resilience, and mood regulation in animal and human research models — without the stimulant-class side effects of conventional cognitive enhancers.

Common Research Pairings

Semax · synergistic neuropeptideSelank · anxiolytic complementPinealon · pineal-axis supportNAD+ · cellular energy substrate

Heptapeptide · Originally isolated from amphibian skin

Dermorphin is a naturally occurring seven-amino-acid peptide first isolated from the skin of South American frogs of the genus Phyllomedusa. It is a remarkably selective μ-opioid receptor agonist — orders of magnitude more potent than morphine on a per-molecule basis — making it an unusual but valuable subject in analgesic and opioid receptor research.

Plain-Language PictureA peptide so potent at engaging the body's pain-suppression switch that researchers study it the way physicists study extreme states of matter — to understand the machinery, not to use it casually.

What It's Being Studied To Do

  • Engage μ-opioid receptors with extraordinary selectivity over κ and δ subtypes
  • Probe the kinetics and binding architecture of opioid receptor signaling
  • Inform the design of safer, less-addictive analgesic compounds
  • Map the molecular boundary between pain perception and reward signaling
  • Support research into peripheral-only analgesia that bypasses central reward pathways

Why This Matters

Pain medicine sits at one of the hardest crossroads in pharmacology — between effective analgesia and dependence risk. Dermorphin's extreme potency and selectivity make it a research tool for understanding what a 'cleaner' opioid signal might look like at the molecular level.

Potential Impact Being Explored

Foundational findings in opioid receptor biology, contributions to the development of next-generation analgesics, and ongoing research into peripheral-only opioid agonists that may someday separate analgesia from reward.

Common Research Pairings

PE-22-28 · neurodepression researchSelank · anxiolytic complementCerebrolysin · neuroprotection supportNAD+ · cellular energy
← 04 · Growth Hormone & Regenerative Axis 06 · Immune & Inflammatory Modulation →